There were 26 press releases posted in the last 24 hours and 168,581 in the last 365 days.

Global Orphan Drug Market Analysis, Share, Trends and Forecast by 2022

Orbis Research

Orbis Research

OrbisResearch.com has published new research report on "Orphan Drug-Global Market Outlook (2016-2022)" to its database.

DALLAS, TEXAS, U.S.A., April 20, 2017 /EINPresswire.com/ -- According to Stratistics MRC, the Global Orphan Drug Market is estimated at $145.89 million in 2016 and is expected to reach $265.63 million by 2022 growing at a CAGR of 10.5% from 2016 to 2022. Rising focus of big pharmaceutical companies on orphan drug improvement, increasing occurrence of rare diseases, government incentives for orphan medicine are some factors favouring the market growth. However, some factors such as high initial investment that leads to higher per patient treatment cost, reimbursement uncertainties and high cost of drug development are hindering the market. North America registered significant growth for the market during the forecast period due to rising healthcare spending, constructive government initiatives, growing occurrence of chronic diseases and small timeline required for orphan drug development.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/255591

Some of the key players in the market include Abbott Laboratories, AbbVie Inc., Alexion Pharmaceuticals, Amgen, Inc., Bayer Healthcare, Boehringer Ingelheim GmbH, Bristol Myers Squibb, Celgene Corporation, F. Hoffmann-La Roche AG, Genentech, Janssen Biotech, Inc.,
Johnson & Johnson, Merck & Co., Inc., Novartis, Pfizer Inc., Roche Holding AG, Sanofi Aventis and Vertex Pharmaceuticals.

Drug Types Covered:
Biological orphan drugs
Non-biological orphan drugs

Applications Covered:
Blood-related disorders
Nephrology
Neurology
Oncology
Infectious diseases
Cystic fibrosis
Other Applications

Technologies Covered:
DNA recombination
Hybridoma and gene mapping
Transgenic
Other Technologies

Buy the report@http://www.orbisresearch.com/contact/purchase/255591

Pharmacological classes Covered:
Enzyme replacement
Gene and chromosome expression
Protein replacement

Indications Covered:
Acute Myeloid Leukemia
Duchenne Muscular Dystrophy
Glioma
Graft vs Host Disease
Multiple Myeloma
Non-Hodgkin Lymphoma
Ovarian Cancer
Pancreatic Cancer
Renal Cell Carcinoma
Other Indications

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Hector Costello
Orbis Research
+1 (214) 884-6817
email us here